Teleflex Incorporated (NYSE:TFX) Given Average Rating of “Moderate Buy” by Analysts

Teleflex Incorporated (NYSE:TFX) has received a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $252.50.

A number of research analysts have recently issued reports on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Mizuho dropped their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Royal Bank of Canada decreased their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st.

Institutional Investors Weigh In On Teleflex

Several institutional investors and hedge funds have recently modified their holdings of the stock. Headlands Technologies LLC purchased a new position in shares of Teleflex during the 4th quarter worth approximately $29,000. Cromwell Holdings LLC boosted its position in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 49 shares in the last quarter. Avior Wealth Management LLC grew its stake in Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new position in Teleflex in the third quarter worth $40,000. Finally, True Wealth Design LLC lifted its position in Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX stock opened at $174.74 on Thursday. The firm has a market cap of $8.12 billion, a P/E ratio of 34.74, a P/E/G ratio of 1.67 and a beta of 1.16. The firm’s fifty day moving average is $177.41 and its 200 day moving average is $208.26. Teleflex has a 52 week low of $165.62 and a 52 week high of $253.06. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.